-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Underweight on Moderna, Raises Price Target to $77

Benzinga·08/21/2026 16:07:58
Listen to the news
JP Morgan analyst Jessica Fye maintains Moderna (NASDAQ:MRNA) with a Underweight and raises the price target from $40 to $77.